Flu challenge study in healthy adults to test an investigational approach
Part of Infections, Lungs & breathing clinical trials.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be able to read, understand, and follow the study instructions and procedures
- Be between 18 and 49 years old, and not be pregnant or breastfeeding
- Use birth control (or abstain) and have negative pregnancy tests before the flu challenge
- Be in generally good health with no major long-term medical problems (especially lungs, heart, immune system, nervous system, or autoimmune diseases)
- Avoid tobacco and avoid certain medications that could change flu symptoms or results during the quarantine period
- Pass the study’s screening checks (quiz, vitals, blood tests, heart tracing, chest imaging, and breathing tests if used)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how healthy adults respond to being exposed to a flu virus in a controlled setting. You will be closely monitored and may help researchers learn more about flu and potential treatments.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.
This study tests a new medicine called TRX-100 to see if it can help fight the flu. Healthy volunteers will be exposed to the influenza A virus in a controlled setting to see how the medicine works.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.